Veridan Wealth’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Veridan Wealth's LLY Position: Q1 2026 in Review
Veridan Wealth increased its Eli Lilly (LLY) stake by 8% in Q1 2026, buying an estimated $21.3K and bringing the position to 283 shares worth $261K. The position accounts for 0.1% of the portfolio, ranked #73.
Veridan Wealth first reported a position in LLY in Q2 2024 and has held it in 5 quarters since. The position peaked at $281K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Veridan Wealth held 283 shares of Eli Lilly worth $261K as of Q1 2026.
- Veridan Wealth bought 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
- Eli Lilly made up 0.1% of Veridan Wealth's portfolio in Q1 2026, its #73 holding.
- Veridan Wealth first reported a position in Eli Lilly in Q2 2024 and has held it in 5 quarters since.
- Veridan Wealth's Eli Lilly position peaked at $281K in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Veridan Wealth's 13F filing for Q1 2026, filed 15 May 2026.